期刊文献+

益生菌在根除幽门螺杆菌治疗中的作用 被引量:29

The effect of probiotics for Helicobacter pylori eradication
下载PDF
导出
摘要 幽门螺杆菌(Helicobacter pylori,H.pylori)感染与上胃肠道疾病密切相关。由于H.pylori对抗生素耐药率的增加及根除治疗过程中不良反应的出现,导致标准三联疗法H.pylori根除率逐渐下降。益生菌辅助治疗H.pylori感染已取得一些成果,其在提高H.pylori根除率、降低不良反应中的作用日益受到重视。在H.pylori根除治疗中何时加用益生菌、加用何种益生菌成为国内外研究的热点,益生菌的疗效很大程度上依赖于菌种或菌株类型。益生菌还具有维持胃肠道微生态的稳定、减轻黏膜炎症反应等多种作用,本文对益生菌在根除H.pylori治疗中的作用机制及临床意义、益生菌在降低H.pylori治疗相关不良反应中的作用作一概述。 Helicobacter pylori (H.pylori) infection is closely associated with the upper gastrointestinal disease.H.pylori eradication rate of standard triple therapy gradually decreases due to increasing antimicrobial resistance and treatment-related side effects.Probiotics combined with standard therapy has certain effects in improving H.pylori eradication rate and reducing side effects.When adding probiotics and what types of probiotics for H.pylori eradication are becoming a hot spot of research at home and abroad.However,the types of species or strains seriously affect therapeutic effect of probiotics.In addition,probiotics have a possible role in the stabilization of the gastric barrier function and reducing mucosal inflammation.In this article,we reviewed the development of research on the mechanisms of action and clinical significance and the causes of reducing side effects of probiotics for H.pylori eradication.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第7期839-842,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 幽门螺杆菌 益生菌 布拉氏酵母菌 嗜酸乳杆菌 Helicobacter pylori Probiotics Saccharomyces boulardii Lactobacillus acidophilus
  • 相关文献

参考文献5

二级参考文献23

  • 1Qin-Juan Sun, Xiao Liang, Qing Zheng, Wei-Qi Gu, WenZhong Liu, Shu-Dong Xiao, Hong Lu.Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai[J].World Journal of Gastroenterology,2010,16(40):5118-5121. 被引量:90
  • 2Graham DY. Can therapy even be denied for Helicobacter pylori infection? Gastroenterology, 1997, 113 (6 Suppl): S113-S117.
  • 3Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ, 1997, 314 (7092): 1430- 1431.
  • 4Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter, 2007, 12 (4): 275-278.
  • 5Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report. Gut, 2007, 56 (6): 772-781.
  • 6Miyoshi M, Mizuno M, Ishiki K, et al. A randomized open trial for comparison of proton pump inhibitors,omeprazole versus rabeprazole, in dual therapy for Helicobacter pflori infection in relation to C~P2C19 genetic polymorphism. J Gastroenterol Hepatol, 2001, 16 (7): 723-728.
  • 7Suzuki T, Matsuo K, Sawaki A, et al. Influence of smoking and CYP2C19 genotypes on H. pylori eradication success. Epidemiol Infect, 2007, 135 (1): 171-176.
  • 8Furuta T, Sugimoto M, Shirai N, et al. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori. Aliment Pharmacol Ther, 2007, 26 (5): 693-703.
  • 9Baker KH,Hegarty JP.Presence of Helicobacter pylori in drinking water is associated with clinical infection[J].Scand J Infect Dis,2001,33(10):744-746.
  • 10Bunn JE,MacKay WG,Thomas JE,et al.Detection of Helicobacter pylori DNA in drinking water biofilms:implications for transmission in early life[J].Lett Appl Microbiol,2002,34(6):4540-4544.

共引文献74

同被引文献264

引证文献29

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部